LYELL IMMUNOPHARMA INC (LYEL) — institutional ownership

99 funds reported holding LYELL IMMUNOPHARMA INC in their latest 13F filings, worth $243M in total (CUSIP 55083R203).

Largest holders

1. ARCH Venture Management, LLC — $45.5M
2. MWG Caph Ltd — $31.0M
3. VANGUARD GROUP INC — $25.4M
4. GSK plc (GSK, GLAXF) — $21.3M
5. MWG Management Ltd. — $16.4M
6. VANGUARD CAPITAL MANAGEMENT LLC — $11.1M
7. Orland Properties Ltd — $10.6M
8. BlackRock, Inc. (BLK) — $10.2M
9. Almitas Capital LLC — $8.17M
10. Foresite Capital Management V, LLC — $6.69M

Famous investors holding it

• Izzy Englander portfolio (Millennium Management)
• Renaissance Technologies portfolio (Renaissance Technologies)
• Ken Griffin portfolio (Citadel Advisors)
• Two Sigma portfolio (Two Sigma Investments)

Insider buying and selling at LYELL IMMUNOPHARMA INC

Who owns the most LYEL stock?

The largest institutional holders in the latest 13F filings are ARCH Venture Management, LLC ($45.5M), MWG Caph Ltd ($31.0M), VANGUARD GROUP INC ($25.4M).

How many funds own LYEL?

99 funds reported holding it, worth $243M in total.